Avadel Pharmaceuticals plc - ADR

NASDAQ:AVDL  
8.23
+0.35 (+4.44%)
Products

Avadel Pharmaceuticals Announces Submission Of New Drug Application For FT218 To FDA

Published: 12/16/2020 14:05 GMT
Avadel Pharmaceuticals plc - ADR (AVDL) - Avadel Pharmaceuticals Announces Submission of New Drug Application for Ft218 to the FDA.